Women Have It Worse in Axial Spondyloarthritis

August 15, 2018

Be careful not to discount the disease burden in women with axSpA.

Reference1. Rusman T, van Vollenhoven RF, van der Horst-Bruinsma IE. Gender differences in axial spondyloarthritis: women are not so lucky. Curr Rheumatol Rep. 2018;20:35. doi: 10.1007/s11926-018-0744-2.

Rusman and fellow researchers at the Amsterdam Rheumatology and Immunology Center in the Netherlands found that although men have worse radiologic prognosis in axial spondyloarthritis (axSpA), women have a higher disease burden that is multifactorial.¹ Thumb through the slides for the details of the study and the take-home points for clinicians.

(Image credit: ©Africa Studio/Shutterstock.com)

axSpA, axial spondyloarthritis; TNFi, tumor necrosis factor inhibitor.

Traditionally, women have been underrepresented in phase 1 and 2 clinical trials.

TNF, tumor necrosis factor.

axSpA, axial spondyloarthritis.

axSpA, axial spondyloarthritis; BASDAI, Bath Ankylosing Spondylitis Disease Activity Index.

AS, ankylosing spondylitis; axSpA, axial spondyloarthritis; TNFi, tumor necrosis factor inhibitor.

axSpA, axial spondyloarthritis.